Davenport & Co’s Genmab GMAB Stock Holding History
Bought
Maintained
Sold
Other funds holding GMAB
PL
LWAM
QCM
SFA
SOAM
GCM
VCM
BTI
CGH
Davenport & Co's GMAB Position: Q2 2026 in Review
Davenport & Co reduced its Genmab (GMAB) stake by 5.2% in Q2 2026, selling an estimated $62.6K and leaving 42,544 shares worth $1.17M. The position accounts for 0.01% of the portfolio, ranked #731.
Davenport & Co first reported a position in GMAB in Q2 2021 and has held it in 19 quarters since. The position peaked at $1.44M in Q3 2023. 41 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.
- Davenport & Co held 42,544 shares of Genmab worth $1.17M as of Q2 2026.
- Davenport & Co sold 2,357 Genmab shares in Q2 2026, an estimated $62.6K.
- Genmab made up 0.01% of Davenport & Co's portfolio in Q2 2026, its #731 holding.
- Davenport & Co first reported a position in Genmab in Q2 2021 and has held it in 19 quarters since.
- Davenport & Co's Genmab position peaked at $1.44M in Q3 2023.
- 41 funds tracked by Wall St. Rank held Genmab as of Q2 2026.
Based on Davenport & Co's 13F filing for Q2 2026, filed 13 Jul 2026.